|
|
|
|
 |
|||
|
|||
doi:10.1369/jhc.5A6853.2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Volume 54 (6): 713-725, 2006
Copyright ©The Histochemical Society, Inc.
Immunocytochemical Study of Amelogenin Deposition during the Early Odontogenesis of Molars in Alendronate-treated Newborn Rats
Laboratory of Mineralized Tissue Biology, Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
Correspondence to: Dr. Victor E. Arana-Chavez, Laboratory of Mineralized Tissue Biology, Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, SP, Brazil. E-mail: vearana{at}usp.br
 |
Summary |
|---|
 Top Summary IntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Newborn rats were treated with sodium alendronate to study how enamel is formed and the effect of alendronate during early odontogenesis. Ultrastructural analysis combined with high-resolution immunocytochemistry for amelogenin was carried out. Twelve rats were subjected to daily SC injections of sodium alendronate (2.5 mg/kg/day) for 3 days on their dorsal region, whereas three rats were daily injected with saline solution as a control. Molar tooth germs from 3-day-old rats were fixed under microwave irradiation in 0.1% glutaraldehyde + 4% formaldehyde buffered at pH 7.2 with 0.1 M sodium cacodylate. The specimens were left undecalcified, postfixed with osmium tetroxide, dehydrated, and embedded in LR White resin. Ultrathin sections were incubated with a chicken anti-24-kDa rat amelogenin antibody, a secondary antibody, and finally with a protein A–gold complex. Large patches of amelogenin were present over the unmineralized mantle dentin and at early secretory ameloblasts. At more advanced stages, they were also detected at the enamel matrix, as well as in the mineralized dentin, at the periodontoblastic space of the dentinal tubules, and at the predentin. It is likely that the main effect of alendronate at early stages of odontogenesis is the increase of synthesis/secretion of amelogenin, promoting its deposition within the forming dentin and enamel. (J Histochem Cytochem 54:713–725, 2006)
Key Words: amelogenin • alendronate • odontogenesis • ameloblasts • odontoblasts • bisphosphonates • immunocytochemistry
|
Introduction |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
ODONTOGENESIS starts with a series of complex cell–cell and cell–matrix interactions that result in differentiation of odontoblasts and ameloblasts, which form dentin and enamel, respectively (Thesleff et al. 1995
). As amelogenesis begins, cells from the inner epithelium of enamel organ undergo a relatively slow differentiation process before they become secretory ameloblasts. Meanwhile, peripheral ectomesenchymal cells of the dental papilla differentiate into odontoblasts and initiate the secretion of dentin [reviewed in Arana-Chavez and Massa (2004)]. Once the mantle dentin is formed, the ameloblasts complete their differentiation and secrete large amounts of a variety of enamel proteins. The secreted enamel proteins assemble to form a complex extracellular enamel matrix that controls the initiation and rate of growth of mineral crystallites [reviewed in Nanci and Smith (1992); Nanci et al. (1998)]. Indeed, the secretory stage of amelogenesis is a unique forming process in which fine interactions take place during secretion of proteins, partial protein degradation, and mineralization of fine crystals (Smith 1998). Thus, any alteration of this equilibrium might result in structural defects of the formed enamel.
Amelogenins are the major components of the developing enamel matrix as they comprise 
90% of all enamel proteins secreted by ameloblasts (Nanci and Smith 1992). Amelogenins are hydrophobic proteins rich in proline, histidine, and glutamine. They are present in small amounts at the beginning of amelogenesis where they are immunodetected as early as the differentiation of ameloblasts starts, i.e., before the secretion of the other enamel proteins (Nanci et al. 1998). It is more evident when highly sensitive methods of immunodetection combined with transmission electron microscopy are applied (Arana-Chavez and Nanci 2001). Many amelogenin cleavage products from proteinase activity and isoforms translated from alternatively spliced mRNA transcripts have been characterized by several researchers in the last 20 years [reviewed in Veis (2003)] Alternative splicing of amelogenin mRNA results in the formation of proteins ranging from 5 to 28 kDa in size (Simmer and Snead 1995). The amelogenin sequences at both carboxy- and N-terminal regions promote their self-assembly into 20-nm-diameter nanospheres, which are thought to play a key role in guiding the growth of enamel crystallites (Fincham et al. 1999; Moradian-Oldak 2001). The action of matrix metalloproteinases, especially MMP-20, on the amelogenin molecules cleavage is crucial for their self-assembly, association with the mineral phase, and degradation and removal from the extracellular matrix [reviewed in Smith (1998)].
Bisphosphonates are pyrophosphate analogs that, because of their similarity to natural pyrophosphate, avidly bind to bone (Fleisch 1987). This property, in addition to their ability to inhibit osteoclastic bone resorption, has led to the use of bisphosphonates in the treatment of skeletal disorders such as osteoporosis, Paget's disease, osteogenesis imperfecta, and metastatic bone diseases (Fleisch 1998; Vasikaran 2001). The molecular mechanisms of action of bisphosphonates on osteoclasts have recently been elucidated. Depending on the presence of a nitrogen atom in the alkyl chain of the molecule, bisphosphonates act either by causing toxic effects on osteoclasts or by interfering with specific intracellular pathways in those cells. Although several studies have suggested that bisphosphonates do not adversely affect the osteoblast activity (Sato et al. 1991; Nii et al. 1994; Rodan and Fleisch 1996; Evans 2002), cells other than osteoclasts may also be affected by bisphosphonates in other mineralized tissues. It has also been reported that bisphosphonates act as inhibitors of mineralization in bone (Francis 1969; King et al. 1971; Schenk et al. 1973) and tooth (Reynolds et al. 1973; Beertsen et al. 1985; Ogawa et al. 1989; Takano et al. 1998; Sakai et al. 1999; Jayawardena et al. 2002). Indeed, administration of bisphosphonates at high and successive doses has been shown to affect mineralization of both dentin and enamel (Simmelink 1987; Izumi 1989; Ohya et al. 1989; Fejerskov et al. 1990; Weile et al. 1990,1993; Fouda et al. 1991; Wakamatsu 1991; Takano et al. 1998). Some light microscopy studies have shown that rats injected with 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) develop enamel hypoplasia due to a disturbance in the enamel protein secretion (Fuangtharnthip et al. 2000; Yamada et al. 2000).
Alendronate is a potent nitrogen-containing bisphosphonate that inhibits enzymes of the mevalonate pathway, thus preventing the prenylation of small GTP-binding proteins that are responsible for the cytoskeletal integrity and for intracellular signaling in osteoclasts (Fisher et al. 1999; van Beek et al. 1999; Bergstrom et al. 2000). Although the mode of action of alendronate is mainly being investigated in bone, little is known about its effects on the formation of dental hard tissues, in particular on enamel.
To test the hypothesis that alendronate may induce some alterations on the early development of enamel, resembling the effects of other bisphosphonates, we have carried out an ultrastructural study on molar tooth germs from alendronate-treated 3-day-old rats combined with the high-resolution immunocytochemical labeling for amelogenin, the major enamel protein secreted at early stages of odontogenesis. Analysis of the effects caused by sodium alendronate on the ameloblast metabolism may elucidate some aspects of the amelogenin function during early odontogenesis. As alendronate is usually administered orally in treatments for osteoporosis and other bone diseases, it would be difficult to determine comparable serum concentrations in the newborn rats. Thus, we have given a daily high dose (2.5 mg/kg/day) of alendronate SC, based on a previous study of the growth plate from long bones in mice (Evans et al. 2003).
|
Materials and Methods |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Animals, Alendronate Treatment, and Tissue Processing
Principles of Laboratory Animal Care (NIH Publication 85-23, revised in 1985) and Brazilian national laws on animal use were observed for the present study, which was authorized by the Ethical Committee for Animal Research of the University of São Paulo, Brazil.
Fifteen 3-day-old Wistar rats weighing 7 g were studied. Twelve rats were subjected to daily SC injections of 2.5 mg/kg/day (Evans et al. 2003) of sodium alendronate (Matéria Prima–Farmácia de Manipulação; São Paulo, Brazil) for 3 days on their dorsal region, whereas three rats were daily injected with saline solution as a control. Two hr after the third injection, the tooth germs were removed and quickly placed in a fixative containing 0.1% glutaraldehyde + 4% formaldehyde (freshly prepared from paraformaldehyde) and buffered at pH 7.4 with 0.1 M sodium cacodylate (Arana-Chavez and Nanci 2001). Briefly, the specimens were immersed in a beaker containing 40 ml of fixative at room temperature, which was subsequently placed in a 20 x 20-cm glass recipient filled with ice and immediately placed inside a Pelco 3440 laboratory microwave oven (Ted Pella; Redding, CA). The temperature probe of the oven was submersed into the fixative, and the specimens were exposed to microwave irradiation at a 100% setting for three periods of 5 min with the temperature programmed to a maximum of 37C (Massa and Arana-Chavez 2000). After microwave irradiation, specimens were transferred into fresh fixative and left overnight at 4C. They were then washed in 0.1 M sodium cacodylate buffer, pH 7.4, for 1 hr, left undecalcified, and postfixed in 0.1 M cacodylate-buffered 1% osmium tetroxide for 1 hr at room temperature or left unosmicated. They were then dehydrated in graded concentrations of ethanol and embedded in LR White resin. Toluidine blue-stained 1-µm-thick sections were examined under a light microscope, and regions containing the sequence of initial stages of odontogenesis were trimmed for ultrathin sectioning. Eighty-nm-thick sections were cut with a diamond knife on a Leica Ultracut R ultramicrotome (Leica Inc.; Buffalo, NY), collected onto 200-mesh nickel grids coated with 2% parlodion in amyl acetate, stained with uranyl acetate and lead citrate, and examined in a Jeol (Tokyo, Japan) 1010 transmission electron microscope operated at 80 kV.
High-resolution Postembedding Immunocytochemistry
Ultrathin sections of osmicated samples were pretreated with an aqueous solution of 5% sodium metaperiodate for 60 min (Bendayan and Zollinger 1983) and washed with distilled water for 15 min. Unosmicated sections were directly processed for immunolabeling. Grids were incubated with a chicken egg yolk anti-rat 24-kDa amelogenin antibody (Nanci et al. 1996) diluted 1:150 for 5 hr and then incubated with a rabbit anti-chicken IgG secondary antibody (Sigma; St Louis, MO), diluted 1:2000 for l hr. The sites of antibody–antigen binding were revealed with a protein A–gold complex, prepared as described in Bendayan (1995). Grids were washed with PBS between incubation steps and blocked with PBS-1% ovalbumin for 15 min. After the protein A–gold, the grids were jet washed with PBS followed by distilled water. All steps were carried out at room temperature. Sections were then stained with uranyl acetate and lead citrate and examined in a Jeol 1010 transmission electron microscope operated at 80 kV. Controls for the specificity of the labeling consisted of incubating the sections with preimmune serum, with the secondary antibody followed by protein A–gold, or with protein A–gold alone.
|
Results |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Ultrastructural Morphology
Examination of ultrathin sections from the alendronate-treated specimens revealed evident alterations in the extracellular matrix at all stages of odontogenesis when compared with the control group. As an example, Figure 1 shows the comparison between a specimen from the alendronate-treated group (Figure 1A) and another from the control group (Figure 1B). At later stages, large patches of electron-opaque granular material were present between the plasma membrane of the ameloblasts at the newly formed enamel matrix. The enamel crystals were placed somewhat disorderedly in the alendronate-treated specimens when compared with the control group (Figures 1A and 1B).
|
At very early stages before the undifferentiated ameloblasts initiated their elongation and reversed their polarity, patches of a conspicuously granular electron-opaque material appeared at their proximal end. They were present in the early unmineralized mantle dentin between the collagen fibrils and matrix vesicles. Electron-opaque granular material was also found along the basolateral surface of ameloblasts among the collagen fibrils and other components of the mantle dentin matrix (Figure 2 ). Thus, during the first stages of odontogenesis the patches of electron-opaque granular material were identified in close relation to the distal surface of differentiating ameloblasts and among the disrupted basal lamina (Figure 3 ). At these stages, a few granular deposits were also observed at the apical surface of the differentiating odontoblasts (Figure 2).
|
|
In stages in which the unmineralized dentin matrix formed a continuous layer, electron-opaque patches present at the distal end of differentiating ameloblasts were smaller than those observed in proximity to the distal end of differentiating odontoblasts (Figure 4 ). When the developing mantle dentin started its mineralization in relation to the matrix vesicles and then spread to the adjacent collagen, the patches of granular electron-opaque material continued to accumulate (data not shown).
|
In more advanced phases, when the mineralized mantle dentin established a continuous band and the secretory stage of amelogenesis began, numerous patches of granular material were present at the distal surface of ameloblasts. They were present at the intercellular spaces (Figure 5 ), as well as into the ameloblast cytoplasm, inside secretory granules (Figure 6 ). As this granular material kept on accumulating, the developing enamel matrix started its mineralization. The nascent enamel crystallites were surrounded by the excess of granular matrix, which was interposed between the ameloblast plasma membrane and the crystals (Figure 6). The mineralized dentin presented small patches of granular material in the interior of the dentinal tubules, occupying the periodontoblastic space in close relation to the odontoblast process (Figure 7 ). In contrast, the patches of granular material were numerous and larger in the predentin, where they appeared to be located below the dentinal tubules and mainly in proximity to the odontoblast processes (Figure 7). The patches of electron-opaque granular material were observed between the odontoblasts but not into the cytoplasm of odontoblasts or at the subodontoblastic region of the dental papilla (see below).
|
|
|
Post-embedding Immunocytochemistry for Amelogenin
As described above, only the early stages of dentinogenesis were somewhat similar between both groups, because from a given time point the presence of large patches were clearly identified in the alendronate-treated group. Thus, at early stages, when the non-treated specimens (control group) were incubated with the anti-amelogenin antibody, the amelogenin 24-kDa molecule was present at the distal cytoplasm of the differentiating ameloblasts and dispersed within the unmineralized dentin matrix in close relation to the basal lamina (Figure 8A ). At slightly more advanced stages, no patches immunoreactive for this protein were observed in the developing dentin matrix (Figure 8B).
|
In the alendronate-treated specimens, the patches of electron-opaque granular material described above were strongly immunoreactive for amelogenin at all studied stages of dentinogenesis and amelogenesis. Amelogenin was detected at early stages of ameloblast differentiation when these cells started the organization of their synthesis and secretion apparatus. The colloidal gold particles were observed inside secretory granules at the distal end and at the early unmineralized dentin matrix where they appeared in close relation to the basal lamina and the newly released matrix vesicles (Figure 9 ) The immunoreactivity for amelogenin at these early stages was somewhat more intense than that observed in the control specimens (compare with Figure 8A). In a slightly more advanced stage, the gold particles formed patches at the unmineralized dentin, which were more concentrated adjacent to the differentiating ameloblasts (Figure 10 ). Later in dentin formation, they were in close relation to the distal surface of odontoblasts, as well as to some projections of the odontoblast cell bodies (Figure 11 ). In the newly mineralized mantle dentin, the patches of amelogenin, which were larger and in a higher amount, were located close to the differentiating odontoblasts and their process (Figure 12 ). At the odontoblast layer, patches strongly immunoreactive for amelogenin were surrounded by projections at the distolateral regions of odontoblasts (Figure 13 ). Other patches with smaller size were also detected between the odontoblasts, at their basolateral sides (see below).
|
|
|
|
|
At later stages, when the mantle dentin was fully mineralized, the ameloblasts were fully differentiated thus starting the secretory stage of amelogenesis. Antibody-colloidal gold complexes immunoreactive for amelogenin were located at perinuclear multivesicular bodies (Figure 14 ) and inside secretory granules at the Golgi apparatus of ameloblasts (Figure 15 ). Amelogenin was also immunodetected forming patches at the intercellular spaces between the distolateral surfaces of ameloblasts, as well as at the developing enamel matrix, where appeared in close relation to the enamel crystals (Figure 16 ). At these stages, small patches of particles were evident inside the dentinal tubules at the periodontoblastic space, whereas the mineralized dentin was not labeled (Figure 17 ). The patches observed at the predentin as well as at the intercellular spaces between odontoblasts were also strongly immunoreactive for amelogenin (Figure 18A ), whereas the odontoblast cytoplasm was never labeled for amelogenin (Figures 18A and 18B).
|
|
|
|
|
|
Discussion |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
The present high-resolution immunocytochemical study showed that sodium alendronate promotes evident disturbances on the early developmental stages of rat molar tooth germs. Numerous amelogenin-containing patches of enamel matrix appeared on the early unmineralized mantle dentin before the onset of the secretory stage of amelogenesis, different from the normal pattern of amelogenin secretion that took place in the control group. Then, amelogenin diffused through the dentin matrix toward the layer of odontoblasts and accumulated in the predentin, assuming an ectopical deposition clearly visible in the alendronate-treated group.
Although it is well established that amelogenin is the major enamel protein and most of the knowledge about its functions has been accumulated in recent years [reviewed in Nanci et al. (1998); Moradian-Oldak (2001)], many questions remain unsolved. The administration of sodium alendronate, which clearly increased the amelogenin secretion by ameloblasts, may help us to elucidate some aspects of the amelogenin function during amelogenesis. As the electron-opaque patches containing granular material strongly immunoreacted with the anti-24-kDa amelogenin antibody, it is reasonable to presume that it consisted of amelogenin. It is possible that when amelogenin is present in high amounts, as in the alendronate-treated specimens, large patches randomly distributed in the unmineralized dentin matrix may be formed due to the hydrophobic N-terminal of the amelogenin molecules similar to the natural aggregation into nanospheres (Fincham et al. 1999). In addition, the amelogenin hydrophobic proprieties, the specific and strong immunolabeling, and the well-preserved ultrastructure of the specimens obtained with the methods applied (Arana-Chavez and Nanci 2001) dismiss the possibility that the patches of granular material found in the present study could be the stippled material caused by poor fixation.
Extracellular granular substance was first described as "precursor substance secreted into the extracellular environment where fibrillogenesis and mineralization is taking place" (Fearnhead 1958), later named "stippled material" (Watson 1960). In the following two decades, studies were carried out investigating the nature of that stippled material during enamel secretion found in different frequency and quantity. However, most of these early ultrastructural studies employed immersion fixation and slow penetrating fixatives such as osmium tetroxide. With the advent of aldehydes and perfusion fixation, stippled material was absent or present in lower amounts, meaning that it depends upon the fixative and the fixation method, i.e., according to Nanci and Warshawsky (1984), stippled material is a fixation artifact.
Immunolabeling of amelogenin over the granular material in the alendronate-treated specimens is consistent with the idea that some chemical agents are capable of provoking secretory alterations on ameloblasts, causing the presence of stippled material. In these cases, the source of the stippled material is not due to poor fixation, but high amounts of amelogenin are actually at the extracellular matrix. There are previous reports of the presence of stippled material when rats were injected with fluoride, strontium, or cobalt ions (Neiman and Eisenmann 1975; Chen and Eisenmann 1984). Similar accumulates of amelogenin appearing as large as patches of granular material have also been detected at the cemento-enamel junction during the earliest stages of root formation in porcine teeth (Bosshardt and Nanci 2004).
Immunoreactivity for amelogenin in both the alendronate-treated and the control specimens was clear at the early stages of ameloblast differentiation when these cells had not yet reversed their polarity and the underlying basal lamina was continuous. A short time later, as mantle dentin started its development, the intensity of immunolabeling for amelogenin in the alendronate-treated molar tooth germs became evidently stronger than in the control group. The exact role for the releasing of amelogenin before the secretory phase of amelogenesis is not clear. It has been reported that the small splice products of the amelogenin gene [A+4] and [A–4] may be secreted in small amounts to act differently as signaling molecules affecting ameloblasts and odontoblasts. [A–4] induces odontoblast differentiation but also hinders the differentiation of ameloblasts (Veis 2003; Tompkins et al. 2005a). [A–4] biotin staining was observed in both differentiating ameloblasts and odontoblasts but vanished at the point of dentin mineralization. The lysosome-associated membrane protein 1 (LAMP-1) is present at the plasma membrane as well as the endosomal/lysosomal membrane of cells (Lippincott-Schwartz and Fambrough 1987), and it is believed to be responsible for the internalization of [A–4] into C2C12 cells (Tompkins et al. 2005b). Thus, amelogenin peptides may induce, together with some growth factors such as TGF-1, BMP 2 and 4, and IGF, the postmitotic outer cells of the dental papilla to differentiate into odontoblasts (Slavkin et al. 1988; Thesleff et al. 1995). The increased amount of 24-kDa amelogenin detected during the presecretory phase, before or at the initial stages of dentinogenesis, has not affected the supposing signaling proprieties, because no abnormality was found at the odontoblast phenotype. The diffusion of small amounts of 24-kDa amelogenin toward dentin has been reported in normal odontogenesis (Nanci et al. 1992; Nakamura et al. 1994; Ruch et al. 1995), but it is generally considered an occasional event (Arana-Chavez and Nanci 2001).
Because there was no immunogold labeling for 24-kDa amelogenin within the cytosol or over secretory organelles of odontoblasts, it is presumed that the high amount of amelogenin labeled within the unmineralized dentin matrix and between the odontoblasts in the alendronate-treated specimens is not a result of the synthesis and secretion by these odontoblasts. Even though it has been reported that odontoblasts express amelogenin mRNA (Veis et al. 2000; Oida et al. 2002) and that amelogenin is expressed in relatively small amounts in a temporal-dependent pattern by rodent odontoblasts (Papagerakis et al. 2003), the odontoblasts were never labeled in either the control or treated specimens, thus confirming previous studies with the same antibody (Nanci et al. 1996; Bosshardt and Nanci 1997; Arana-Chavez and Nanci 2001). At least 14 isoforms are translated by an alternative splicing that takes place during amelogenin processing (Tompkins et al. 2005b). Thus, previous studies may have detected other amelogenin molecules in odontoblasts different from that recognized by the antibody used here. In addition, expression of mRNA, where a signal is detected by in situ hybridization, does not necessarily imply that it will be translated into its final protein, or that some nascent molecules may be intracellularly degraded immediately after synthesis by enamelysin (MMP-20) or other matrix metalloproteinases (MMPs) [reviewed in Nanci and Smith (1992); Bourd-Boittin et al. (2004)]. Thus, it is reasonable to assume that the total amount of amelogenin labeled at the forming dentin and between odontoblasts in alendronate-treated specimens was synthesized and secreted by the developing ameloblasts, which yields the amelogenin diffusion toward dentin. Indeed, differentiating and fully differentiated ameloblasts contained many secretory granules labeled with the chicken egg yolk anti-24-kDa amelogenin antibody, whereas the gold particles at the odontoblast layer were observed only at the intercellular spaces.
As odontogenesis progressed, the patches of amelogenin observed in the treated specimens continued to be significantly larger than those observed in the control group. The patches were detected at the forming enamel layer, at the dentinal tubules of the mineralized dentin, and at the predentin near the distal end of the odontoblast. Because the examined ultrathin sections represent individual moments of odontogenesis, which is a dynamic and continuous process, it is likely that the patches represented the "footprints" left by amelogenin during its diffusion pathway toward the dentin.
Although bisphosphonates possess a well-known antiosteoclastic effect (Vasikaran 2001; van Beek et al. 2002; Reszka and Rodan 2004), it has also been recognized that they have high dose-dependent physicochemical proprieties (Baumann et al. 1978) that interfere with the transformation of amorphous calcium phosphate into hydroxyapatite (Fleisch 1998). On the other hand, bisphosphonates have effects on matrix formation (Larson 1974; Van den Boss and Beertsen 1987; Ogawa et al. 1989; Takano et al. 1998; Fuangtharnthip et al. 2000) including disrupting effects on mineralization. In fact, several data have been reported about dentin and enamel hypomineralization in rat incisors induced by HEBP administration: the inhibition of dentin mineralization subsequently promotes the failure of enamel protein secretion and deposition resulting in clear enamel-free zones that interrupt the continuity of the enamel layer (Ogawa et al. 1989; Fuangtharnthip et al. 2000). However, as hydroxyapatite crystals have been clearly discerned in dentin and enamel, it is likely that the nucleation of minerals is not affected by the sodium alendronate treatment. Thus, it may have a lower disrupting effect on mineralization than other bisphosphonates such as HEBP, which produces several enamel hypoplasias when administered SC at similar doses. Whereas those studies evaluated both dentinogenesis and amelogenesis in decalcified rat incisors under light microscopy (Ogawa et al. 1989; Fuangtharnthip et al. 2000), our specimens were intentionally left undecalcified to discern the appearance and distribution of mineral crystals in both dentin and enamel matrices.
Taking the morphological and immunocytochemical results obtained here, it is likely that the main effect of alendronate is a break into the equilibrium of secretion/degradation of amelogenin in enamel matrix that is controlled by ameloblasts throughout the secretory stage of amelogenesis. Indeed, although our results suggest that molecules of amelogenin are oversecreted by ameloblasts, it is possible that they could be insufficiently degraded during the secretory stage of amelogenesis. Because bisphosphonates have been reported to inhibit MMPs (Heikkila et al. 2002), they may act during odontogenesis by affecting the function of MMP-20 (enamelysin) or other enzymes that act during the secretory stage of amelogenesis.
In addition to the above considerations, it is possible that similar morphological alterations would occur in human teeth after administration of high doses of alendronate during odontogenesis. The available experimental studies investigating the effects of bisphosphonates on tooth formation have been made by examining rat incisors (Fuangtharnthip et al. 2000; Yamada et al. 2000), which display continuous growth and eruption. The analysis of rat molar tooth germs carried out here offers the advantage of having the several stages of odontogenesis at a same slope of a given developing cusp. In addition, this model permits a better correlation to the sequential events of odontogenesis that take place in human teeth. It may be important because sodium alendronate is a drug broadly used in therapies for many bone pathologies, including its administration to pregnant women or children (McCarthy et al. 2002; Maasalu et al. 2003). In fact, the stages of molar tooth germs examined in the newborn rats take place intrauterine during the odontogenesis of human primary (deciduous) teeth and during early childhood for development of permanent teeth.
|
Acknowledgments |
|---|
This work was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp) (01/13782-0 and 04/05831-9) and Conselho Nacional de Pesquisas (CNPq) (Brazil).
The authors thank Dr. Antonio Nanci (University of Montreal, Montreal, Canada) for supplying the anti-24-kDa rat amelogenin antibody and Miss Sylvia Zalzal for preparing the protein A–gold complex. We also thank Mr. Gaspar F. de Lima for ultrathin sectioning and Mr. Edson Oliveira for printing the electron micrographs.
|
Footnotes |
|---|
Received for publication October 5, 2005; accepted January 23, 2006
|
Literature Cited |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Arana-Chavez VE, Massa LF (2004) Odontoblasts: the cells forming and maintaining dentine. Int J Biochem Cell Biol 36:1367–1373[Medline]
Arana-Chavez VE, Nanci A (2001) High-resolution immunocytochemistry of noncollagenous matrix proteins in rat mandibles processed with microwave irradiation. J Histochem Cytochem 49:1099–1110
Baumann JM, Bisaz S, Fleisch H, Wacker M (1978) Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate in calcium nephrolithiasis. Clin Sci Mol Med 554:509–516
Beertsen W, Niehof A, Everts V (1985) Effects of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on the formation of dentin and the periodontal attachment apparatus in the mouse. Am J Anat 174:83–103[CrossRef][Medline]
Bendayan M (1995) Colloidal gold post-embedding immunocytochemistry. Prog Histochem Cytochem 29:1–159[Medline]
Bendayan M, Zollinger M (1983) Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique. J Histochem Cytochem 31:101–109[Abstract]
Bergstrom JD, Bostedor RG, Masarachia PJ, Rezka AA, Rodan G (2000) Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphonate synthase. Arch Biochem Biophys 373:231–241[CrossRef][Medline]
Bosshardt DD, Nanci A (1997) Immunodectection of enamel- and cementum-related (bone) proteins at the enamel-free area and cervical portion of the tooth in rat molars. J Bone Miner Res 12:367–379[CrossRef][Medline]
Bosshardt DD, Nanci A (2004) Hertwig's epithelial root sheath, enamel matrix proteins, and initiation of cementogenesis in porcine teeth. J Clin Periodontol 31:184–192[Medline]
Bourd-Boittin K, Septier D, Hall R, Goldberg M, Menashi S (2004) Immunolocalization of enamelysin (matrix metalloproteinase-20) in the forming rat incisor. J Histochem Cytochem 52:437–445
Chen S, Eisenmann DR (1984) Ultrastructural study of the effects of fixation and fluoride injection on stippled material during amelogenesis in the rat. Arch Oral Biol 29:681–686[Medline]
Evans CE (2002) Bisphosphonates modulate the effect of macrophage-like cells on osteoblast. Int J Biochem Cell Biol 34:554–563[Medline]
Evans KD, Lau ST, Oberbauer AM, Martin RB (2003) Alendronate affects long bone and growth plate morphology in the oim mouse model for osteogenesis imperfecta. Bone 32:268–274[Medline]
Fearnhead RW (1958) Observations on the plasmal reaction applied to myelinated nerves. Acta Anat (Basel) 32:312–321[Medline]
Fejerskov O, Josephsen K, Weile V (1990) The effect of a single dose of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on secretory ameloblasts and enamel formation in rat incisors. J Biol Buccale 18:339–354[Medline]
Fincham AG, Moradian-Oldak J, Simmer JP (1999) The structural biology of the developing dental enamel matrix. J Struct Biol 126:270–299[CrossRef][Medline]
Fisher JE, Rogers MJ, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russel RGG, et al. (1999) Alendronate mechanism of action: geranygeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption and kinase activation in vitro. Proc Natl Acad Sci USA 96:133–138
Fleisch H (1987) Bisphosphonates—history and experimental basis. Bone 8:23–28[Medline]
Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19:80–100
Fouda N, Caracatsanis M, Kut IA, Hammarstrom L (1991) Mineralization disturbances of the developing rat molar induced by mono- and bisphosphonates. J Biol Buccale 19:106–115[Medline]
Francis MD (1969) The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates. Calcif Tissue Res 3:151–162[CrossRef][Medline]
Fuangtharnthip P, Yamada Y, Takagi Y, Ohya K (2000) Autoradiographic investigation of the effect of 1-hydroxyethylidene-1, 1-bisphosphonate on matrix protein synthesis and secretion by secretory ameloblasts in rat incisors. Arch Oral Biol 45:495–506[Medline]
Heikkila P, Teronen O, Moilanen M, Konttinen YT, Hanemaaijer R, Laitinen M, Maisi P, et al. (2002) Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anticancer Drugs 13:245–254[CrossRef][Medline]
Izumi T (1989) Effects of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on the unimpeded eruption rate and the dental hard tissue formation in rat mandibular incisor. Nippon Yakurigaku Zasshi 93:75–87[Medline]
Jayawardena CK, Takahashi N, Watanabe E, Takano Y (2002) On the origin of intrinsic matrix of acellular extrinsic fiber cementum: studies on growing cementum pearls of normal and bisphosphonate-affected guinea pig molars. Eur J Oral Sci 110:261–269[Medline]
King WR, Francis MD, Michael WR (1971) Effect of disodium ethane-1-hydroxy-1, 1-diphosphonate on bone formation. Clin Orthop 78:251–270[CrossRef][Medline]
Larson A (1974) The short-term effects of high doses of ethylene-1-hydroxy-1,1-diphosphonates upon early dentin formation. Calcif Tissue Res 16:109–127[CrossRef][Medline]
Lippincott-Schwartz J, Fambrough DM (1987) Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: kinetic and morphological analysis. Cell 49:669–677[CrossRef][Medline]
Maasalu K, Haviko T, Martson A (2003) Treatment of children with Osteogenesis Imperfecta in Estonia. Acta Paediatr 92:452–455[Medline]
Massa LF, Arana-Chavez VE (2000) Ultrastructural preservation of rat embryonic dental tissues after rapid fixation and dehydration under microwave irradiation. Eur J Oral Sci 108:74–77
McCarthy EA, Raggio CL, Hossack MD, Miller EA, Jain S, Boskey AL, Camacho NP (2002) Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res 52:660–670[CrossRef][Medline]
Moradian-Oldak J (2001) Amelogenins: assembly, processing and control of crystal morphology. Matrix Biol 20:293–305[CrossRef][Medline]
Nakamura M, Bringas P, Nanci A, Zeichner-David M, Ashdown B, Slavkin HC (1994) Translocation of enamel proteins from inner enamel epithelia to odontoblasts during mouse tooth development. Anat Rec 238:383–396[CrossRef][Medline]
Nanci A, Hashimoto J, Zalzal S, Smith CE (1996) Transient accumulation of proteins at interrod and rod enamel growth sites. Adv Dent Res 10:135–149[Medline]
Nanci A, McKee MD, Smith CE (1992) Immunolocalization of enamel proteins during amelogenesis in the cat. Anat Rec 233:335–349[Medline]
Nanci, A, Smith CE (1992) Development and calcification of enamel. In Bonucci E, ed. Calcification in Biological Systems. Boca Raton, FL, CRC Press, 313–343
Nanci A, Warshawsky H (1984) Relationship between the quality of fixation and the presence of stippled material in newly formed enamel of the rat incisor. Anat Rec 208:15–31[CrossRef][Medline]
Nanci A, Zalzal S, Lavoie P, Kunikata M, Chen WY, Krebsbach PH, Yamada Y, et al. (1998) Comparative immunochemical analyses of developmental expression and distribution of ameloblastin and amelogenin in rat incisors. J Histochem Cytochem 46:911–934
Neiman A, Eisenmann DR (1975) The effect of strontium, cobalt and fluoride on rat incisor enamel formation. Anat Rec 183:303–321[Medline]
Nii A, Fujimoto R, Okazaki A, Narita K, Miki H (1994) Intramembranous and endochondral bone changes induced by a new bisphosphonate (YM175) in the beagle dog. Toxicol Pathol 22:536–544[Medline]
Ogawa Y, Adachi Y, Hong S, Yagi T (1989) 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) simultaneously induces two distinct types of hypomineralization in the rat incisor dentine. Calcif Tissue Int 44:46–60[Medline]
Ohya K, Mataki S, Wakamatsu H, Ogura H (1989) Effects of successive injections of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on the rat incisors enamel. In Fearnhead RW, ed. Tooth Enamel V, Yokohama, Florence Publishers, 227–234
Oida S, Nagano T, Yamakoshi Y, Ando H, Yamada M, Fukae M (2002) Amelogenin gene expression in porcine odontoblasts. J Dent Res 81:103–108
Papagerakis P, MacDougall M, Hotton D, Bailleul-Forestier I, Oboeuf M, Berdal A (2003) Expression of amelogenin in odontoblasts. Bone 32:228–240[Medline]
Reszka AA, Rodan GA (2004) Nitrogen-containing bisphosphonate mechanism of action. Mini Rev Med Chem 4:711–719[Medline]
Reynolds JJ, Minkin C, Morgan DB, Spycher D, Fleisch H (1973) Inhibition of bisphosphonates of bone resorption in mice and comparison with gray-lethal osteoporosis. Calcif Tissue Res 12:59–71[CrossRef][Medline]
Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97:2692–2696[Medline]
Ruch JV, Lesot H, Begue-Kim C (1995) Odontoblast differentiation. Int J Dev Biol 39:51–68[Medline]
Sakai H, Takano Y, Ohya K, Kurosaki N (1999) Intermittent inhibition of dentin mineralization of rat incisors under continual infusion of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) using subcutaneous mini osmotic pump. Arch Histol Cytol 62:171–179[Medline]
Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, et al. (1991) Bisphosphonates action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095–2105[Medline]
Schenk R, Merz WA, Mühlbauer R, Russell RGG, Fleisch H (1973) Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196–214[Medline]
Simmelink JW (1987) Ultrastructural effects of diphosphonates on dental enamel. Adv Dent Res 1:356–365[Abstract]
Simmer, JP, Snead M (1995) Molecular biology of the amelogenin gene. In Robinson C, Kirkham J, Shore R, eds. Dental Enamel Formation to Destruction. Boca Raton, CRC Press, 59–84
Slavkin HC, Bessem C, Bringas PJR, Zeichner-David M, Nanci A, Snead ML (1988) Sequential expression and differential function of multiple enamel proteins during fetal neonatal and early postnatal stages of mouse molar organogenesis. Differentiation 37:26–39[CrossRef][Medline]
Smith CE (1998) Cellular and chemical events during enamel maturation. Crit Rev Oral Biol Med 9:128–161
Takano Y, Sakai H, Baba O, Sakamoto Y, Terashima T, Ohya K, Kurosaki N (1998) Demonstration of putative Ca-binding domains in dentin matrix of rat incisors after daily injections of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP). Eur J Oral Sci 106:274–281[Medline]
Thesleff I, Vaahtokari A, Kettunen P, Aberg T (1995) Epithelial-mesenchymal signaling during tooth development. Connect Tissue Res 32:9–15[Medline]
Tompkins K, Alvares K, George A, Veis A (2005a) Two related low molecular mass polypeptide isoforms of amelogenin have distinct activities in mouse tooth germ differentiation in vitro. J Bone Miner Res 20:341–349[CrossRef][Medline]
Tompkins K, George A, Veis A (2005b) Characterization of a mouse amelogenin [A-4]/M59 cell surface receptor. Bone in press.
van Beek ER, Löwik CWGM, Papapoulous SE (2002) Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors. Bone 30:64–70[Medline]
van Beek E, Pieterman E, Cohen L, Lowik C, Papapoulos S (1999) Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo. Biochem Biophys Res Commun 263:754–758[CrossRef][Medline]
Van den Bos T, Beertsen W (1987) Effects of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the synthesis of dentin matrix proteins on the mouse. Coll Rel Res 7:135–147[Medline]
Vasikaran SD, (2001) Bisphosphonates: an overview with special reference to alendronate. Ann Clin Biochem 38:608–623[CrossRef][Medline]
Veis A (2003) Amelogenin splice gene products: potential signaling molecules. Cell Mol Life Sci 60:30–55
Veis A, Tompkins K, Alvares K, Wei K, Wang L, Wang XS, Brownell AG, et al. (2000) Specific amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo. J Biol Chem 275:41263–41272
Wakamatsu H (1991) A study of the effects of successive injections of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the enamel formation of rat incisor. Jpn J Oral Biol 33:82–96
Watson ML, (1960) The extracellular nature of enamel in the rat. J Biophys Biochem Cytol 7:489–492[Medline]
Weile V, Josephsen K, Fejerskov O (1990) Effects of single doses of 1-hydroxyethylidene-1,1-bisphosphonate on the mineralizing front of rat incisor enamel: a microradiographic and scanning electron microscopic study. Arch Oral Biol 35:857–867[CrossRef][Medline]
Weile, V, Josephsen K, Fejerskov O (1993) Scanning electron microscopy of final enamel formation in rat mandibular incisors following single injections of 1-hydroxyethylidene-1,1-bisphosphonate. Calcif Tissue Int
Yamada Y, Fuangtharnthip P, Takagi Y, Ohya K (2000) Gene expression and immunolocalization of amelogenin in enamel hypoplasia induced by successive injections of bisphosphonate in rat incisors. Arch Oral Biol 45:207–215[CrossRef][Medline]